Fisher & Paykel Healthcare Corporation Limited (FSPKF) Comparison with companies in other sectors?

Fisher & Paykel Healthcare Corporation Limited has a share price of 586.27M. You can analyze Fisher & Paykel Healthcare Corporation Limited (FSPKF) competitors across different market sectors through stock heatmaps.

What are FSPKF's NET and operating margins?

Fisher & Paykel Healthcare Corporation Limited (FSPKF) operating margin is around -0.07, and net profit margin is approximately 0.24 as of the latest reports.

In what way does FSPKF's earnings per share (EPS) trend reflect its financial momentum?

Fisher & Paykel Healthcare Corporation Limited (FSPKF) EPS is 0.38 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Fisher & Paykel Healthcare Corporation Limited is 52.66, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Fisher & Paykel Healthcare Corporation Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Fisher & Paykel Healthcare Corporation Limited like P/E which is 37.44, P/B which is 10.50, and PEG which is 0.11. Compare them with sector averages to evaluate if the stock is priced fairly.

Fisher & Paykel Healthcare Corporation Limited

FSPKF•PNK

Healthcare

Medical - Instruments & Supplies

$20.01

$0.00(0.00%)

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$0.38

P/E Ratio

52.66

ROE

0.28%

Net Margin

0.24%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$11.73B

Shares OutstandingTotal number of shares issued

$586.27M

Book Value/ShareNet worth per share

$3.23

Revenue/ShareAnnual revenue per share

$3.81

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$0.38

Net MarginNet income as percentage of revenue

23.77%

Operating MarginOperating income as percentage of revenue

-6.85%

ROEReturn on shareholders' equity

27.77%

ROAReturn on total assets

20.79%

ROCEReturn on capital employed

-7.46%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$1.09

Cash/ShareCash and equivalents per share

$0.45

FCF YieldFree cash flow as percentage of market cap

3.22%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$0.50

Dividend YieldAnnual dividend as percentage of stock price

1.48%

Financial Ratios Analysis data is not available for FSPKFFinancial Ratios Analysis details for FSPKF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for FSPKFSector Benchmarking details for FSPKF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Fisher & Paykel Healthcare Corporation Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Fisher & Paykel Healthcare Corporation Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Fisher & Paykel Healthcare Corporation Limited's unique business strengths and challenges.

Key Financial Metrics for Fisher & Paykel Healthcare Corporation Limited

For Fisher & Paykel Healthcare Corporation Limited, essential financial indicators include EPS 0.38, PE 52.66, and ROE 0.28. These key ratios reveal insights into Fisher & Paykel Healthcare Corporation Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Fisher & Paykel Healthcare Corporation Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Fisher & Paykel Healthcare Corporation Limited

Metrics like Net Margin 23.77% and ROA 20.79% shed light on how well Fisher & Paykel Healthcare Corporation Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Fisher & Paykel Healthcare Corporation Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Fisher & Paykel Healthcare Corporation Limited

Using ratios such as P/B Ratio 10.50 and PEG Ratio 0.11, investors can assess whether Fisher & Paykel Healthcare Corporation Limited is appropriately valued based on its financials and growth potential. These figures, combined with Fisher & Paykel Healthcare Corporation Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Fisher & Paykel Healthcare Corporation Limited

Financial health indicators, such as Debt/Equity Ratio 0.08 and Cash Flow $1.09, provide a snapshot of Fisher & Paykel Healthcare Corporation Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Fisher & Paykel Healthcare Corporation Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Fisher & Paykel Healthcare Corporation Limited

Investing in Fisher & Paykel Healthcare Corporation Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Fisher & Paykel Healthcare Corporation Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;